vs

Side-by-side financial comparison of EASTERN CO (EML) and HIVE Digital Technologies Ltd. (HIVE). Click either name above to swap in a different company.

HIVE Digital Technologies Ltd. is the larger business by last-quarter revenue ($93.1M vs $55.3M, roughly 1.7× EASTERN CO). EASTERN CO runs the higher net margin — 1.0% vs -98.1%, a 99.1% gap on every dollar of revenue. On growth, HIVE Digital Technologies Ltd. posted the faster year-over-year revenue change (218.6% vs -22.4%). Over the past eight quarters, HIVE Digital Technologies Ltd.'s revenue compounded faster (102.2% CAGR vs -0.6%).

China Eastern Airlines is a major airline in China, headquartered in Changning, Shanghai. It is one of the three major airlines in the country, along with Air China and China Southern Airlines.

Mastech Digital, Inc. is a digital transformation and information technology (IT) services company headquartered in Pittsburgh, Pennsylvania, providing services to corporations across North America, Middle East, Asian, and Japan.

EML vs HIVE — Head-to-Head

Bigger by revenue
HIVE
HIVE
1.7× larger
HIVE
$93.1M
$55.3M
EML
Growing faster (revenue YoY)
HIVE
HIVE
+240.9% gap
HIVE
218.6%
-22.4%
EML
Higher net margin
EML
EML
99.1% more per $
EML
1.0%
-98.1%
HIVE
Faster 2-yr revenue CAGR
HIVE
HIVE
Annualised
HIVE
102.2%
-0.6%
EML

Income Statement — Q3 FY2025 vs Q3 FY2026

Metric
EML
EML
HIVE
HIVE
Revenue
$55.3M
$93.1M
Net Profit
$578.9K
$-91.3M
Gross Margin
22.3%
-27.1%
Operating Margin
3.1%
Net Margin
1.0%
-98.1%
Revenue YoY
-22.4%
218.6%
Net Profit YoY
103.8%
-234.0%
EPS (diluted)
$0.10
$-0.38

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
EML
EML
HIVE
HIVE
Q4 25
$93.1M
Q3 25
$55.3M
$87.3M
Q2 25
$70.2M
$45.6M
Q1 25
$63.3M
Q4 24
$64.3M
$29.2M
Q3 24
$71.3M
$22.6M
Q2 24
$72.6M
$32.2M
Q1 24
$64.6M
Net Profit
EML
EML
HIVE
HIVE
Q4 25
$-91.3M
Q3 25
$578.9K
$-15.8M
Q2 25
$3.4M
$35.0M
Q1 25
$1.9M
Q4 24
$1.3M
$68.2M
Q3 24
$-15.3M
$80.0K
Q2 24
$3.5M
$-18.3M
Q1 24
$1.9M
Gross Margin
EML
EML
HIVE
HIVE
Q4 25
-27.1%
Q3 25
22.3%
4.7%
Q2 25
23.3%
-13.6%
Q1 25
22.4%
Q4 24
23.6%
-43.7%
Q3 24
25.5%
-66.1%
Q2 24
25.4%
-7.4%
Q1 24
23.9%
Operating Margin
EML
EML
HIVE
HIVE
Q4 25
Q3 25
3.1%
Q2 25
4.5%
Q1 25
5.1%
Q4 24
6.1%
Q3 24
9.5%
Q2 24
8.3%
Q1 24
5.3%
Net Margin
EML
EML
HIVE
HIVE
Q4 25
-98.1%
Q3 25
1.0%
-18.1%
Q2 25
4.9%
76.8%
Q1 25
3.1%
Q4 24
2.0%
233.2%
Q3 24
-21.5%
0.4%
Q2 24
4.8%
-56.7%
Q1 24
3.0%
EPS (diluted)
EML
EML
HIVE
HIVE
Q4 25
$-0.38
Q3 25
$0.10
$-0.07
Q2 25
$0.56
$0.18
Q1 25
$0.32
Q4 24
$0.22
$0.52
Q3 24
$-2.46
$0.00
Q2 24
$0.56
$-0.17
Q1 24
$0.31

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
EML
EML
HIVE
HIVE
Cash + ST InvestmentsLiquidity on hand
$9.2M
Total DebtLower is stronger
Stockholders' EquityBook value
$124.3M
$559.3M
Total Assets
$220.0M
$624.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
EML
EML
HIVE
HIVE
Q4 25
Q3 25
$9.2M
Q2 25
$9.1M
Q1 25
$10.2M
Q4 24
$16.1M
$40.5M
Q3 24
$9.7M
$31.7M
Q2 24
$2.0M
Q1 24
$2.1M
Total Debt
EML
EML
HIVE
HIVE
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$42.2M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
EML
EML
HIVE
HIVE
Q4 25
$559.3M
Q3 25
$124.3M
$624.6M
Q2 25
$124.4M
$560.5M
Q1 25
$121.0M
Q4 24
$120.7M
$430.9M
Q3 24
$119.2M
$275.5M
Q2 24
$136.5M
$268.6M
Q1 24
$134.5M
Total Assets
EML
EML
HIVE
HIVE
Q4 25
$624.0M
Q3 25
$220.0M
$693.0M
Q2 25
$229.4M
$628.7M
Q1 25
$232.3M
Q4 24
$235.3M
$478.6M
Q3 24
$244.2M
$334.7M
Q2 24
$255.9M
Q1 24
$253.9M
Debt / Equity
EML
EML
HIVE
HIVE
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.35×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
EML
EML
HIVE
HIVE
Operating Cash FlowLast quarter
$3.1M
$46.0M
Free Cash FlowOCF − Capex
$3.1M
FCF MarginFCF / Revenue
5.5%
Capex IntensityCapex / Revenue
0.1%
Cash ConversionOCF / Net Profit
5.38×
TTM Free Cash FlowTrailing 4 quarters
$12.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
EML
EML
HIVE
HIVE
Q4 25
$46.0M
Q3 25
$3.1M
$-10.6M
Q2 25
$3.8M
$10.2M
Q1 25
$-1.8M
Q4 24
$11.0M
$-28.5M
Q3 24
$-2.9M
$-2.2M
Q2 24
$8.4M
$-4.4M
Q1 24
$2.8M
Free Cash Flow
EML
EML
HIVE
HIVE
Q4 25
Q3 25
$3.1M
Q2 25
$3.0M
Q1 25
$-2.7M
Q4 24
$9.0M
$-55.5M
Q3 24
$-7.7M
$-34.7M
Q2 24
$7.3M
Q1 24
$1.1M
FCF Margin
EML
EML
HIVE
HIVE
Q4 25
Q3 25
5.5%
Q2 25
4.3%
Q1 25
-4.3%
Q4 24
13.9%
-189.9%
Q3 24
-10.8%
-153.4%
Q2 24
10.1%
Q1 24
1.7%
Capex Intensity
EML
EML
HIVE
HIVE
Q4 25
Q3 25
0.1%
Q2 25
1.1%
Q1 25
1.3%
Q4 24
3.2%
92.5%
Q3 24
6.7%
143.9%
Q2 24
1.5%
Q1 24
2.6%
Cash Conversion
EML
EML
HIVE
HIVE
Q4 25
Q3 25
5.38×
Q2 25
1.09×
0.29×
Q1 25
-0.95×
Q4 24
8.41×
-0.42×
Q3 24
-26.94×
Q2 24
2.40×
Q1 24
1.43×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons